Evidence map›Paper›PMID 32409243›Full record

GuidelineArchivos de la Sociedad Espanola de Oftalmologia2020

Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.

J A Gegúndez-Fernández, J Zarranz-Ventura, G Garay-Aramburu, F J Muñoz-Negrete, J Mendicute Del Barrio, L Pablo-Júlvez, S García-Delpech, A López-Alemany, F Arnalich-Montiel, M Cordero-Coma and 2 more

Open access · greenAbstract readPractice GuidelineReview
In one paragraph

Guideline in Archivos de la Sociedad Espanola de Oftalmologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Article
  9. [Impact of COVID-19 on the provision of essential health services in Paraguay].Revista panamericana de salud publica = Pan American journal of public health · 2020
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

J A Gegúndez-FernándezHospital Clínico San Carlos, Sociedad Española de Oftalmología (SEO), Madrid, España. Electronic address: doctorgegundez@gmail.com.
J Zarranz-VenturaHospital Clinic, Sociedad Española de Retina y Vítreo (SERV) Barcelona, España.
G Garay-AramburuOSI Araba, Sociedad Española de Retina y Vítreo (SERV), Vitoria-Gasteiz, España.
F J Muñoz-NegreteHospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO) y Sociedad Española de Glaucoma (SEG), Madrid, España.
J Mendicute Del BarrioHospital Universitario de Donostia, Sociedad Española de Cirugía Ocular Implanto-Refractiva (SECOIR), San Sebastián, España.
L Pablo-JúlvezHospital Universitario Miguel Servet, Sociedad Española de Glaucoma (SEG), Zaragoza, España.
S García-DelpechHospital Universitario La Fe, Sociedad Española de Contactología (SEC) y Sociedad Española de Oftalmología (SEO), Valencia, España.
A López-AlemanyUniversidad de Valencia, Sociedad Española de Contactología (SEC), Xátiva, Valencia, España.
F Arnalich-MontielHospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO), Madrid, España.
M Cordero-ComaHospital Universitario de Léon, Sociedad Española de Inflamación Ocular (SEIOC), León, España.
J A CárcelesClínica Coatvisión, Sociedad Española de Oftalmología (SEO), Murcia, España.
Sociedades oftalmológicas españolas
Biogipuzkoa Health Research Institute · ESHospital Clínico San Carlos · ESHospital de León · ESHospital Universitario Miguel Servet · ESHospital Universitario Ramón y Cajal · ESInstitut Català de Retina · ESSociedad Española de Farmacología Clínica · ESSociedad Española de Nefrología · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMinimize exposure to the SARS-CoV-2, reduce the chances of cross-transmission between patients and healthcare personnel, and prevent the development of postoperative complications from the management of patients with eye diseases during the 2019 coronavirus disease pandemic (COVID-19).

methodsCOVID-19 literature review and consensus establishment between different Spanish ophthalmology societies in order to provide guidelines and recommendations of maximum resources primarily conditioned by the state of alert, confinement and social distancing that occurs in Spain since March 16, 2020.

resultsThe recommendations will promote the adoption of action and protection measures for eye care in outpatient clinics, surgical areas and hospitalization, for unconfirmed (asymptomatic and symptomatic) and confirmed COVID-19 patients. Measures must be adapted to the circumstances and availability of personal protective equipment in each of the centers and Autonomous Communities, which will be updated according to the pandemic phases and the measures adopted by the Spanish Government.

conclusionsDuring the COVID-19 pandemic, attention to the potential health risks to the population caused by coronavirus should prevail over the possible progression of the common eye diseases. Ophthalmologists and other eye care professionals must assume a possible progression of these diseases due to the impossibility of adequate patient follow-up.

Indexed as

BetacoronavirusPandemicsAntimalarialsAsymptomatic DiseasesBlood SafetyChloroquineContact LensesCoronavirus InfectionsCOVID-19Disease ProgressionEye DiseasesHumansHydroxychloroquineInfectious Disease Transmission, Patient-to-ProfessionalOphthalmologic Surgical ProceduresOphthalmologyAntimalarialsChloroquineHydroxychloroquineAtención oftalmológicaCOVID-19Eye careOftalmologíaOphthalmologyPandemiaPandemicRecomendacionesRecommendationsSARS-CoV-2

Identifiers

PMID32409243
PMCPMC7183292
OpenAlexW3019021962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.